- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06649578
Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks
October 20, 2024 updated by: National University Hospital, Singapore
Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks: Insights From a Decade-Long Cohort Study of 1016 Patients
While metabolic-bariatric surgery is a safe and well-established surgery, complications do occur and can have significant impact on the patient.
With the study, the investigators aim to establish the proportion of patients that will have complications and understand what the impact of complications are on costs.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Complications after metabolic-bariatric surgery can be catastrophic and have significant impact on costs, morbidity, and mortality.
As current global benchmarks for complications rates in MBS are based on standard risk patients in western populations, the benchmark complication rates in high-risk patients and Asian populations are unknown.
The investigators aim to evaluate the incidence of complications in 1016 consecutive patients and the impact of complications on costs.
Study Type
Observational
Enrollment (Actual)
1016
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Singapore, Singapore, 119074
- National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Our patients are consecutive patients that underwent metabolic-bariatric surgery.
Description
Inclusion Criteria:
- The inclusion criteria were patients who underwent either primary or revisional MBS comprising Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).
Exclusion Criteria:
- Patients under 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Metabolic-Bariatric Surgery
Patients undergoing Metabolic-Bariatric Surgery are divided into either Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).
|
Our study is conducted in a predominantly high-risk Asian population that will be undergoing metabolic-bariatric surgery.
The types of surgery can be divided into Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass (RYGB) or One-Anastomosis Gastric Bypass (OAGB).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants with Anastomotic Leak
Time Frame: From completion of surgery till post-operative 90 days
|
90 Day Post-Operative Complications
|
From completion of surgery till post-operative 90 days
|
|
Number of Participants with Bleeding
Time Frame: From completion of surgery till post-operative 90 days
|
90 Day Post-Operative Complications
|
From completion of surgery till post-operative 90 days
|
|
Number of Participants with Perforation
Time Frame: Time Frame: From completion of surgery till post-operative 90 days
|
90 Day Post-Operative Complications
|
Time Frame: From completion of surgery till post-operative 90 days
|
|
Number of Participants with Collection
Time Frame: Time Frame: From completion of surgery till post-operative 90 days
|
Collection includes hematoma, pus, serous fluids.
Outcome measured to 90 Day Post-Operative.
|
Time Frame: From completion of surgery till post-operative 90 days
|
|
Number of Participants with Hospital Readmission
Time Frame: From completion of surgery till post-operative 90 days
|
Any readmission to hospital from completion of surgery till post-operative 90 days
|
From completion of surgery till post-operative 90 days
|
|
Number of Participants with Reoperation
Time Frame: From completion of surgery till post-operative 90 days
|
Any reoperation due to any complications from completion of surgery till post-operative 90 days
|
From completion of surgery till post-operative 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Costs of Bariatric Surgery (USD)
Time Frame: From completion of surgery till post-operative 90 days
|
Total costs of all events that occur from surgery till post-operative 90 days will be included.
Costs will be extracted from hospital records.
|
From completion of surgery till post-operative 90 days
|
|
Time to surgical intervention (hr)
Time Frame: From completion of surgery till 90 days post-operative
|
Time to surgical intervention for patients requiring surgical treatment for post-operative complications.
Time will be extracted from surgical records
|
From completion of surgery till 90 days post-operative
|
|
Number of Participants with Total Parental Nutrition Requirement
Time Frame: From completion of surgery till post-operative 90 days
|
Use of Total Parental Nutrition during 90 Day Post-Operative
|
From completion of surgery till post-operative 90 days
|
|
Number of Participants with Blood Transfusion
Time Frame: From completion of surgery till post-operative 90 days
|
Any blood transfusion given from completion of surgery till post-operative 90 days
|
From completion of surgery till post-operative 90 days
|
|
Length of Stay (Days)
Time Frame: From completion of surgery till hospital discharge assessed up to post-operative 90 days
|
Length of hospital stay from index operation to hospital discharge
|
From completion of surgery till hospital discharge assessed up to post-operative 90 days
|
|
Number of Participants with Emergency Department Attendance
Time Frame: From completion of surgery till post-operative 90 days
|
Any Emergency Department Attendance from completion of surgery till post-operative 90 days
|
From completion of surgery till post-operative 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Asim Shabbir, MBBS, FRCS, National University Hospital, Singapore
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.
- Gero D, Raptis DA, Vleeschouwers W, van Veldhuisen SL, Martin AS, Xiao Y, Galvao M, Giorgi M, Benois M, Espinoza F, Hollyman M, Lloyd A, Hosa H, Schmidt H, Garcia-Galocha JL, van de Vrande S, Chiappetta S, Menzo EL, Aboud CM, Luthy SG, Orchard P, Rothe S, Prager G, Pournaras DJ, Cohen R, Rosenthal R, Weiner R, Himpens J, Torres A, Higa K, Welbourn R, Berry M, Boza C, Iannelli A, Vithiananthan S, Ramos A, Olbers T, Sepulveda M, Hazebroek EJ, Dillemans B, Staiger RD, Puhan MA, Peterli R, Bueter M. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Ann Surg. 2019 Nov;270(5):859-867. doi: 10.1097/SLA.0000000000003512.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2010
Primary Completion (Actual)
February 1, 2023
Study Completion (Actual)
April 1, 2023
Study Registration Dates
First Submitted
October 8, 2024
First Submitted That Met QC Criteria
October 14, 2024
First Posted (Actual)
October 21, 2024
Study Record Updates
Last Update Posted (Actual)
October 23, 2024
Last Update Submitted That Met QC Criteria
October 20, 2024
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2022/00303
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Data will be shared upon reasonable request towards corresponding author.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complications
-
Saint-Joseph UniversityNot yet recruitingCardiac Surgery | Cardiac Complications | Respiratory Complications | Neurologic Complications
-
University Hospital, GrenobleCompletedHemorrhagic Complications | Cardiovascular ComplicationsFrance
-
Western Galilee Hospital-NahariyaCompletedPost Operative Complications | Intra-operative ComplicationsIsrael
-
Cairo UniversityUnknownCesarean Section Complications | Spinal Anesthetic ComplicationsEgypt
-
Hospital for Special Surgery, New YorkMedical College of WisconsinRecruitingComplications; Arthroplasty | Complications; Arthroplasty, MechanicalUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingPrematurity | Neurodevelopment Outcome | Prematurity ComplicationsFrance
-
Superior UniversityActive, not recruitingSurgery-ComplicationsPakistan
-
Duke UniversityWithdrawnSurgical Complications From Surgery | Surgical Complications From Bladder Surgery | Surgical Complications From Bowel Surgery
-
Mehmet IncebıyikCompletedPelvic Floor Dysfunction | Labor Complications | Pelvic Floor Muscle Training | Perineal TraumaTurkey (Türkiye)
-
PilloxaTerminatedLiver Transplant; Complications | Kidney Transplant; ComplicationsSweden
Clinical Trials on Metabolic-bariatric surgery
-
Pennington Biomedical Research CenterRecruiting
-
Jinan University GuangzhouChinese Obesity and Metabolic Surgery CollaborativeRecruitingObesity | Weight Loss | Bariatric Surgery | Metabolic SurgeryChina
-
British Obesity and Metabolic Surgery SocietyCompleted
-
Medical University of BialystokUniversity of CopenhagenRecruitingObesity | Diabetes Mellitus | Metabolic Syndrome | Dyslipidemias | PreDiabetesPoland
-
King's College LondonUnknownNon-alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steato-Hepatitis (NASH)United Kingdom
-
Sana Klinikum OffenbachWuerzburg University Hospital; Kuwait University; Cleveland Clinic Florida; SRH...CompletedBariatric Surgery Status in T1DGermany
-
McGill University Health Centre/Research Institute...CompletedSingle Anastomosis Duodeno-ileal Bypass With Sleeve Gastrectomy (SADI-S): A Prospective Cohort StudyObesity | Morbid ObesityCanada
-
San Raffaele Telematic UniversityCompletedBariatric Surgery | Nutritional Deficiency | Obesity and Overweight
-
Centre Hospitalier Universitaire de NiceTerminatedObesity | Chronic Kidney DiseaseFrance
-
Imperial College LondonRecruitingObesity | Type 2 DiabetesIreland